surmount-1 trial tirzepatide weight loss nondiabetic SURMOUNT-1: In an RCT, adults with obesity treated with weekly had major over 72 weeks. #ADA2022 https://t.co/X2RrvYxzsV Tirzepatide as Compared with Semaglutide
Description
This synergistic combination is why it outperformed earlier GLP-1 monotherapies like semaglutide
Seuls les mdecins spcialistes en endocrinologie-diabtologie-nutrition ou comptents en nutrition ( savoir titulaire dun DESC, dune FST ou dune VAE de nutrition) peuvent le prescrire une personne, g de moins de 65 ans, ayant un indice de masse corporel (IMC) initial suprieure ou gale 35 kg/m2
Track carefully during this hold period to establish a firm baseline
Mistake 2: reading the syringe from the wrong reference point Insulin syringes have a rubber plunger tip that creates a slight optical illusion
